Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,464 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort.
Rouyer M, Smith D, Laurent C, Becouarn Y, Guimbaud R, Michel P, Tubiana-Mathieu N, Balestra A, Jové J, Robinson P, Noize P, Moore N, Ravaud A, Fourrier-Réglat A; ETNA study group. Rouyer M, et al. Among authors: robinson p. Target Oncol. 2016 Feb;11(1):83-92. doi: 10.1007/s11523-015-0377-6. Target Oncol. 2016. PMID: 26298481
Real-life patterns of use and effectiveness of bortezomib: the VESUVE cohort study.
Fourrier-Réglat A, Noize P, Facon T, Fermand JP, Fitoussi O, Marit G, Thomaré P, Robinson P, Bignon E, Jové J, Lassalle R, Rouyer M, Grelaud A, Moore N; VESUVE Study Group. Fourrier-Réglat A, et al. Among authors: robinson p. Leuk Lymphoma. 2014 Apr;55(4):848-54. doi: 10.3109/10428194.2013.806801. Epub 2013 Aug 28. Leuk Lymphoma. 2014. PMID: 23808815
Patterns and effectiveness of bortezomib use according to age in the VESUVE cohort.
Grelaud A, Fourrier-Réglat A, Fitoussi O, Facon T, Jové J, Bénichou J, Robinson P, Marit G, Rouyer M, Moore N, Noize P; VESUVE Study Group. Grelaud A, et al. Among authors: robinson p. Leuk Lymphoma. 2016;57(6):1349-54. doi: 10.3109/10428194.2015.1096354. Epub 2015 Nov 16. Leuk Lymphoma. 2016. PMID: 26397802
Effectiveness and safety of first-line bevacizumab plus FOLFIRI in elderly patients with metastatic colorectal cancer: Results of the ETNA observational cohort.
Rouyer M, Fourrier-Réglat A, Smith D, Becouarn Y, Guimbaud R, Tubiana-Mathieu N, Robinson P, Jové J, Grelaud A, Noize P, Moore N, Ravaud A. Rouyer M, et al. Among authors: robinson p. J Geriatr Oncol. 2016 May;7(3):187-94. doi: 10.1016/j.jgo.2016.03.004. Epub 2016 Apr 14. J Geriatr Oncol. 2016. PMID: 27085302
Real-life patterns of use, safety and effectiveness of sunitinib in first-line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study.
Noize P, Grelaud A, Bay JO, Chevreau C, Gross-Goupil M, Culine S, Ferrière JM, Moulin F, Robinson P, Balestra A, Lamarque S, Bernard MA, Lassalle R, Rouyer M, Droz-Perroteau C, Moore N, Fourrier-Réglat A, Ravaud A. Noize P, et al. Among authors: robinson p. Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1561-1569. doi: 10.1002/pds.4228. Epub 2017 Jun 1. Pharmacoepidemiol Drug Saf. 2017. PMID: 28573786
Effectiveness of Cetuximab as First-Line Therapy for Patients With Wild-Type KRAS and Unresectable Metastatic Colorectal Cancer in Real-Life Practice: Results of the EREBUS Cohort.
Rouyer M, François E, Cunha AS, Monnereau A, Noize P, Robinson P, Droz-Perroteau C, Le Monies de Sagazan A, Jové J, Lassalle R, Moore N, Fourrier-Réglat A, Smith D; EREBUS Study Group. Rouyer M, et al. Among authors: robinson p. Clin Colorectal Cancer. 2018 Jun;17(2):129-139. doi: 10.1016/j.clcc.2018.01.007. Epub 2018 Jan 31. Clin Colorectal Cancer. 2018. PMID: 29523416
Continuation rates of levetiracetam in children from the EULEVp cohort study.
Dureau-Pournin C, Pédespan JM, Droz-Perroteau C, Lavernhe G, Mann M, Pollet C, Robinson P, Jové J, Moore N, Fourrier-Réglat A; EULEV study group. Dureau-Pournin C, et al. Among authors: robinson p. Eur J Paediatr Neurol. 2014 Jan;18(1):19-24. doi: 10.1016/j.ejpn.2013.07.003. Epub 2013 Sep 10. Eur J Paediatr Neurol. 2014. PMID: 24035600
The EULEV cohort study: rates of and factors associated with continuation of levetiracetam after 1 year.
Droz-Perroteau C, Dureau-Pournin C, Vespignani H, Marchal C, Blin P, Blazejewski S, Pollet C, Jové J, Robinson P, Moore N, Fourrier-Réglat A; EULEV Study Group. Droz-Perroteau C, et al. Among authors: robinson p. Br J Clin Pharmacol. 2011 Jan;71(1):121-7. doi: 10.1111/j.1365-2125.2010.03805.x. Br J Clin Pharmacol. 2011. PMID: 21143508 Free PMC article.
4,464 results